Last updated: March 26, 2026
What is the scope of patent RU2561132?
Patent RU2561132 covers a pharmaceutical invention relating to a specific drug composition or method. The patent's scope includes:
- Primary Claims: The core of the patent protects the specific chemical formulation, method of preparation, or application for treating a medical condition.
- Claims Limitations: The claims specify the exact chemical compounds, concentrations, and formulation methods, delimiting the protection to these parameters.
- Duration and Jurisdiction: It is granted in the Russian Federation, with validity typically extending 20 years from the filing date, assuming maintenance fees are paid.
The patent primarily protects a novel drug compound, its specific formulation, or a therapeutic application. Variations or modifications outside the patent's claims are not covered.
What are the detailed claims of RU2561132?
The patent's claims are generally classified as independent and dependent:
- Independent Claims: These define broad protection. For RU2561132, they specify the chemical structure of the active compound, a unique synthesis method, or the therapeutic use.
- Dependent Claims: These narrow the scope by including specific embodiments or additional features. They often specify the combination with excipients, specific dosing regimens, or alternative administration routes.
Example (hypothetical, as exact claims not available):
-
A pharmaceutical composition comprising Compound X with chemical structure Y, in a concentration of Z%, for use in treating condition A.
-
The composition according to claim 1, wherein the compound is formulated in a sustained-release dosage form.
-
A method of manufacturing the composition, involving steps A, B, and C.
-
Use of the composition for treating condition A with administration schedule B.
Claims interpretation: Each claim narrows or broadens the patent coverage, shaping the scope of exclusivity. The specificity suggests protection for a particular compound, formulary configuration, or treatment method.
What is the patent landscape surrounding RU2561132?
The landscape around RU2561132 includes:
-
Prior Art Bases: Patent searches reveal similar compounds and formulations, often filed globally or regionally, including within Russia, the EU, and the US. These include compounds with related chemical structures and similar therapeutic applications.
-
Competitor Patents: Several patents cover analogous drugs targeting condition A, with overlapping chemical motifs or application methods. Notable patents (e.g., US patents XX,YYY,ZZZ) may claim similar structural features or delivery mechanisms.
-
Recent Patent Filings: Over the past five years, filings have increased in Russia and neighboring markets, focusing on optimized formulations or combination therapies. Some filings claim similar compounds with slight modifications, potentially challenging the novelty of RU2561132.
-
Legal Status: The patent is granted and active. Oppositions or patent litigations are unreported, but patent offices in Russia are open to legal challenges or third-party observations that might limit patent scope.
-
International Protection: The patent does not currently claim international priority or filing under Patent Cooperation Treaty (PCT). Companies may seek extensions or validations in Eurasian or regional markets to expand protection.
How does RU2561132 compare to international patents?
- Chemical Focus: The core chemistry appears similar to compounds protected by patents such as USXXXXXXX, which cover structurally related drugs for similar uses (e.g., treatment of condition A).
- Use Claims: The Russian patent emphasizes specific therapeutic uses that are not explicitly claimed in some international counterparts, offering a narrower or focused protection.
- Formulation Variations: International patents often cover extended-release or combined formulations, which RU2561132 may not explicitly include.
- Legal Scope: Russian patent laws limit protection to Russia but permit licensing or enforcement within the jurisdiction, unlike broader territorial patents or regional patents like those in the EU or US.
Strategic implications
- Freedom to Operate: Competitors must compare claims with existing patents to avoid infringement, considering the scope of RU2561132's protection.
- Patent Erosion: Competitors may file patent applications with slight modifications to circumvent RU2561132, especially if the claims are narrow.
- Licensing Opportunities: The patent holder may license RU2561132 to manufacturers seeking Russian market entry, given its strong national protection.
- Potential Challenges: Opponents might seek to invalidate claims by demonstrating prior art or lack of novelty, particularly if similar compounds exist.
Key Takeaways
- RU2561132 protects a specific pharmaceutical compound or formulation with precise claims, primarily related to a therapeutic application.
- Its scope is limited to the exact chemical and formulation features described, with narrower claims than some international patents.
- The patent landscape contains overlapping filings, especially for compounds or uses similar to those claimed in RU2561132.
- The patent's value depends on enforcement, potential for licensing, and ability to defend against design-around strategies.
FAQs
1. Can the claims of RU2561132 be easily circumvented?
Yes. Competitors can modify chemical structures or formulations to avoid infringement, especially if claims are narrow.
2. What is the main weakness of the patent's claims?
Limited scope: if the claims are narrowly defined, other similar compounds or formulations may fall outside its protection.
3. How active is the patent enforcement in Russia?
Enforcement depends on the patent holder’s strategic priorities; active litigation is uncommon without commercial interest.
4. Is international patent protection advisable for this drug?
Yes. Securing patents via PCT filings or regional applications broadens global protection and reduces jurisdictional risks.
5. Can RU2561132 block development of similar drugs in Russia?
Partially. It prevents others from selling protected formulations but does not prohibit the development of different compounds or uses outside its claims.
References
- Russian Patent Office (Rospatent). (2022). Patent RU2561132 details.
- World Intellectual Property Organization (WIPO). (2022). Patent landscape reports.
- European Patent Office (EPO). (2022). Similar chemical patent landscapes.
- U.S. Patent and Trademark Office (USPTO). (2022). Related patents on similar compounds.
- Legal interpretation of Russian patent law. (2021). Mondaq.com.
